Follow the Latest News from IMS

The 2nd Immune Effector Cell Therapies in Multiple Myeloma Workshop begins tomorrow Learn more here: http://ow.ly/M41950EEBEZ

There's still time to register for the @Myeloma_Society 2nd Immune Effector Cell Therapies in MM workshop. Meet in-person in #Boston or participate virtually May 7-8! Learn more here: http://ow.ly/M41950EEBEZ

Register today for the @Myeloma_Society 2nd Immune Effector Cell Therapies in MM Workshop May 7-8, 2021. Learn more here: http://ow.ly/UPcS50EC1Wp

Register today for @Myeloma_Society 2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop May 7-8!
Learn more here: https://www.myelomasociety.org/events/2nd-immune-effector-cell-therapy-in-multiple-myeloma-workshop/

Register today for @Myeloma_Society 2nd Immune Effector Cell Therapy in Multiple Myeloma Workshop May 7-8!
Learn more here: https://www.myelomasociety.org/meetings/upcoming-meetings.php

Breaking News: lde-cel (Abecma; idecabtagene vicleucel), approved by FDA for multiple myeloma.

This is the first CAR-T therapy for myeloma. Many patients have been waiting for this good news. @agarwalonc @BMS_Myeloma_US @bluebirdbio https://news.bms.com/news/corporate-financial/2021/U.S.-Food-and-Drug-Administration-Approves-Bristol-Myers-Squibbs-and-bluebird-bios-Abecma-idecabtagene-vicleucel-the-First-Anti-BCMA-CAR-T-Cell-Therapy-for-Relapsed-or-Refractory-Multiple-Myeloma/default.aspx

Register today for @Myeloma_Society Immune Effector Cell Therapy in Multiple Myeloma Workshop May 7-8. Learn more here: http://ow.ly/W85w50DUa95

Register today for @Myeloma_Society Immune and Cellular Therapies in MM Workshop May 7-8! https://www.myelomasociety.org/meetings.php

. @Myeloma_Society has developed Recommendations for #Covid-19 #vaccination in patients with multiple myeloma (MM) and related conditions. http://ow.ly/oMq050DsOfC

Applications for the @Myeloma_Society and Paula and Rodger Riney Foundation Translational Research Grant are due on February 15! Learn more here: http://ow.ly/gzsL50CTkYj

Applications for the @Myeloma_Society Career Development Award are now due on 2/15/21! These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1

.@Myeloma_Society is proud to announce the "International Myeloma Society (IMS) and Paula and Rodger Riney Foundation Translational Research Grant." Applications are due 2/15/21. Learn more here: http://ow.ly/gzsL50CTkYj

Apply for the @Myeloma_Society Career Development Award due on 1/15/21! These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1

The deadline for the Career Development Award has been extended to January 15, 2021! Learn more here:
http://ow.ly/4VlS50Ck3U1

Register today for the North America Virtual Educational Workshop with @Myeloma_Society November 6-7! http://ow.ly/tIHD50BEuOS

Apply for the @Myeloma_Society Career Development Award due on 11/15. These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1

Join @Myeloma_Society North America Virtual Educational Workshop November 6-7! Register here http://ow.ly/tIHD50BEuOS

Apply for the @Myeloma_Society Career Development Award due on 11/15. These grants will support young investigators focused on research in the field of plasma cell dyscrasia. Learn more here: http://ow.ly/m9wO50BFqU1

Register today for the North America Virtual Educational Workshop with @Myeloma_Society November 6-7! http://ow.ly/tIHD50BEuOS

Load More...

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events